Target intelligence / Profile preview

Microbiome balance factors

Molecular classification
Other
01

Overview

"Microbiome balance factors" is a non-specific, collective term referring to the myriad of intrinsic (genetics, age, immune function) and extrinsic (diet, antibiotics, lifestyle, infections) elements that govern the composition, diversity, and functional output of the microbiome, particularly in the gastrointestinal tract[1][3][5][9]. Unlike distinct molecular targets, microbiome balance is an ecosystem-level concept: it encompasses regulatory processes that maintain a favorable ratio of beneficial to potentially pathogenic microbes, proper production of microbial metabolites (such as short-chain fatty acids), synthesis of essential vitamins, and modulation of the host's immune responses[3][4][5]. Disruption of these balance factors (dysbiosis) is linked to various diseases including obesity, diabetes, inflammatory bowel disease, infections, some cancers, and neurological disorders[2][7][9][10]. Interventions often target these factors globally, using prebiotics, probiotics, antibiotics, dietary changes, or fecal microbiota transplantation, but there is no single molecule or receptor that defines "microbiome balance factors"[1][3][5][7][9].

Other names
Microbiome balanceGut microbiome balancingMicrobiota balanceGut microbiota composition
02

Mechanism of action

Modulation of microbial community by promoting beneficial strains Suppression of pathogenic or harmful microorganisms Enhancement of short-chain fatty acid (SCFA) production Improvement of gut barrier function Alteration of immune responses

03

Biological functions

Regulation of microbial community structureMaintenance of gut homeostasisImmune modulationNutrient metabolismSynthesis of vitaminsBarrier integrity
04

Disease associations

Inflammatory diseasesMetabolic disorders (obesity, type 2 diabetes)InfectionsImmune-related diseasesNeurological disordersCancer
05

Safety considerations

Potential for dysbiosis with improper interventionRisk of infection with fecal transplantationAntibiotic resistanceAllergic or immune reactions to probiotics
06

Interacting drugs

Probiotics (e.g., Lactobacillus, Bifidobacterium supplements)

3 more in the full profile.

07

Biomarkers

Microbial diversity indices (e.g., Shannon index)Relative abundance of key taxa (e.g., Bacteroides, Firmicutes)SCFA levels (acetate, butyrate, propionate)Metagenomic signatures of gut healthPresence of pathogenic strains (e.g., Clostridioides difficile, Helicobacter pylori)

Beyond the preview

Go deeper on Microbiome balance factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiome balance factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call